Studies have shown that high levels of glucose and angiotensin II (Ang II) stimulate hypertrophy and the expression of matrix protein genes in mouse proximal tubular cells in vitro. The present study tested the hypothesis that blockade of the renin-angiotensin system (RAS) inhibits the stimulatory effect of high levels of glucose on the expression of the renal angiotensinogen (ANG) gene and the formation of Ang II and subsequently attenuates the induction of hypertrophy in kidney proximal tubular cells. Immortalized rat proximal tubular cells (IRPTC) were cultured in monolayer. The levels of expression of rat ANG and ANG mRNA in the IRPTC were quantified by specific radioimmunoassays for rat ANG (RIA-rANG) and by a reverse-transcription polymerase chain reaction (RT-PCR) assay, respectively. Hypertrophy of IRPTC was analyzed by flow cytometry (FACScan) and cellular protein assay. Our studies showed that losartan (an Ang II (AT1)-receptor blocker), perindopril and captopril (inhibitors of angiotensin-converting enzyme) blocked the stimulatory effect of a high level of glucose (i.e. 25 mM) on the expression of the rat ANG gene and hypertrophy in IRPTC but not by the Ang II (AT2)-receptor blocker. Our studies indicate that the blockade of RAS is effective in inhibiting the stimulatory effect of hyperglycemia on the expression of the ANG gene and hypertrophy in IRPTC, supporting the notion that the local formation of intrarenal Ang II may play a role in the development of renal hypertrophy during early diabetes.

1.
Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, Haverty TP: High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol 1990;259:F704–F714.
2.
Wolf G, Neilson EG: Angiotensin II induces cellular hypertrophy in cultured murine tubular cells. Am J Physiol 1990;259:F768–F777.
3.
Wolf G, Neilson EG, Goldfarb S, Ziyadeh FN: The influence of glucose concentration of angiotensin II-induced hypertrophy of proximal tubular cells in culture. Biochem Biophys Res Commun 1991;179:902–909.
4.
Wolf G, Killen PD, Neilson EG: Intracellular signalling of transcription and secretion of type IV collagen after angiotensin II-induced cellular hypertrophy in cultured proximal tubular cells. Cell Regul 1991;2:219–227.
5.
Rocco M, Chen Y, Goldfarb S, Ziyadeh FN: Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule. Kidney Int 1992;41:107–114.
6.
Wolf G, Zahner G, Mondorf U, Schoeppe W, Stahl RAK: Angiotensin II stimulates cellular hypertrophy of LLC-PK1 cells through the AT1 receptor. Nephrol Dial Transplant 1993;8:128–133.
7.
Wolf G, Mueller E, Stahl RAK, Ziyadeh FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 1993;92:1366–1372.
8.
Bakris GL: Angiotensin-converting enzyme inhibitors and the progression of diabetic nephropathy. Ann Intern Med 1993;118:643–644.
9.
Lewis EJ, Hunsicker LG, Bain KP, Rhode RD: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456–1462.
10.
Ichikawa I: Will angiotensin II receptor antagonists be renoprotective in humans? Kidney Int 1996:50:684–692.
11.
Gandhi SK, Ryder DH, Brown NJ: Losartan blocks aldosterone and renal vascular responses to angiotensin II in humans. Hypertension 1996;28:961–966.
12.
Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, Dzau VJ: In situ hybridization evidence for angiotensinogen mRNA in the rat proximal tubule. A hypothesis for the intrarenal renin angiotensin system. J Clin Invest 1990;85:417–423.
13.
Wolf G, Neilson EG: Angiotensin II as a hypertrophogenic cytokine for proximal tubular cells. Kidney Int 1993;43(suppl 39):100–107.
14.
Chen M, Harris MP, Rose D, Smart A, He XR, Kretzler M, Briggs JP, Schnermann J: Renin and renin mRNA in proximal tubule of the rat kidney. J Clin Invest 1994;94:237–243.
15.
Tang SS, Jung FF, Diamant D, Brown D, Bachinsky D, Hellman P, Ingelfinger JR: Temperature-sensitive SV40 immortalized rat proximal tubule cell line has functional renin-angiotensin system. Am J Physiol 1995;268:F435–F436.
16.
Wang L, Lei C, Zhang SL, Roberts KD, Tang SS, Ingelfinger JR, Chan JSD: Synergistic effect of dexamethasone and isoproterenol on the expression of angiotensinogen in immortalized rat proximal tubular cells. Kidney Int 1998;53:287–295.
17.
Zhang SL, Filep JG, Hohman TC, Tang SS, Ingelfinger JR, Chan JSD: Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney Int 1999;55:454–464.
18.
Ingelfinger JR, Jung F, Dramant D, Haveran L, Lee E, Brem A, Tang SS: Rat proximal tubule cell line transformed with origin-defective SV40 DNA: Autocrine Ang II feedback. Am J Physiol 1999;276:F218–F227.
19.
Samuels HH, Standby F, Shapiro LE: Control of growth hormone synthesis in cultured GH cells by 3,5,3′-triiodo-L-thyronine and glucocorticoid agonists and antagonists: Studies on the independent and synergistic regulation of the growth hormone response. Biochemistry 1979;18:715–721.
20.
Ohkubo H, Kageyama R, Ujihara M, Hirose T, Inayama S, Nakanishi S: Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc Natl Acad Sci USA 1983;80:2196–3000.
21.
Nudel U, Zakut R, Shani M, Neuman S, Levy Z, Yaffe D: The nucleotide sequence of the rat cytoplasmic β-acting gene. Nucleic Acid Res 1983;11:1759–1771.
22.
Markwell MAK, Haas SM, Tolbert NE, Bieber LL: Protein determination in membrane and lipoprotein samples: Manual and automated procedures. Methods Enzymol 1981;72:296–303.
23.
Mackovic-Basic M, Fine LG, Normal JT, Cragoe EJ, Kurtz I: Stimulation of Na+/H+ exchanger is not required for induction of hypertrophy in cells in vitro. J Am Soc Nephrol 1992;3:1124–1130.
24.
Seikaly MG, Arant BS, Seney FD, Rutlege L, Green J: Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 1990;86:1352–1357.
25.
Braam B, Mitchell KD, Fox J, Navar LG: Proximal tubular secretion of angiotensin II in rats. Am J Physiol 1993;264:F891–F898.
26.
Navar LG, Lewis L, Hymel A, Braam B, Mitchell KD: Tubular fluid concentrations and kidney contents of angiotensin I and II in anesthesized rats. J Am Soc Nephrol 1994;5:1153–1158.
27.
Schunkert H, Ingelfinger JR, Jacob H, Jackson B, Bouyonnes B, Dzau VJ: Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by Ang II. Am J Physiol 1992;263:E863–E869.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.